MarketResearch.biz delivers in-depth insights on the global endocrine testing market in its upcoming report titled, “Global Endocrine Testing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027”. The global endocrine testing market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the global endocrine testing market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the global endocrine testing market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global endocrine testing market report has been segmented on the basis of test type, technology, end-user, and region.
Endocrine test is used to measure functioning of endocrine gland by checking hormone levels in the body. Endocrine system includes glands in body which make hormones. These hormones play an important role in making sure body works. Endocrine test detects any imbalances in hormonal levels in an individual’s body.
Increasing incidence of endocrine disorders such as diabetes, infertility, thyroid disorders, etc. and high prevalence rate of obesity are key factors driving growth of the global endocrine testing market. In addition, rising demand for consumption of high-sugar foods and technological advancements in endocrine testing equipment in terms of accuracy are other major factors expected to boost growth of the global endocrine testing market over the forecast period.
However, high cost of endocrine equipment and testing is a key factor restraining growth of the global endocrine testing market. Additionally, limited awareness about endocrine testing and high operational costs are other major factors expected to hamper growth of the global endocrine testing market over the forecast period.
Developments in endocrine testing such as in liquid chromatography-mass spectrometry (LC-MS) is expected to provide opportunities for players in the market to expand their presence over the forecast period. Also, increasing incidences of endocrine disorders and growing awareness about healthcare in emerging economies are expected to boost demand of endocrine testing to a significant extent.
Currently, the market in North America dominates the global endocrine testing market in revenue terms owing to presence of well-developed hospitals, government funding for better healthcare services, and increasing health awareness among individuals in countries in the region. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing number of patients suffering from endocrine disorders, and growing government initiatives for improvement of healthcare facilities in countries in the region.
Global endocrine testing market segmentation by test type:
- Estradiol (E2) test
- Follicle Stimulating Hormone (FSH) test
- Human Chorionic Gonadotropin (hCG) hormone test
- Luteinizing Hormone (LH) test
- Dehydroepiandrosterone sulfate (DHEAS) test
- Progesterone test
- Testosterone test
- Thyroid Stimulating Hormone (TSH) test
Global endocrine testing market segmentation by technology:
- Tandem Mass Spectrometry
- Immunoassay Technology
- Monoclonal and Polyclonal Antibody Technology
- Sensors Technology
- Clinical Chemistry Technology
Global endocrine testing market segmentation by end-user:
- Commercial Laboratories
- Ambulatory Care Centers
- Home-based tests
Global endocrine testing market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Abbott Laboratories
- AB Sciex LLC.
- Agilent Technologies, Inc.
- Biomedical Technologies Inc.
- bioMérieux SA
- Bio-Rad Laboratories, Inc.
- DiaSorin S.p.A.
- Hoffmann-La Roche Ltd.
- Laboratory Corporation of America Holdings
- Siemens AG
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!